
Loading, please wait...

Loading, please wait...

Morbihan disease presents a diagnostic challenge for clinicians managing chronic, persistent facial and periorbital edema. Specifically, Morbihan disease management requires a thorough understanding of its clinical presentation to avoid delayed diagnosis and permanent tissue changes. A recent retrospective study evaluated twenty-four patients to determine the most effective therapeutic approaches for this rare condition. All patients in the study exhibited bilateral eyelid involvement, while many also demonstrated extrafacial symptoms. Consequently, clinicians must recognize the characteristic firm, non-pitting edema that distinguishes this condition from common angioedema. Furthermore, histopathological examination remains a valuable tool for confirming the diagnosis, often revealing dilated lymphatic vessels.
The study categorized treatments into observation, oral steroids, intralesional injections, and combination therapies. Notably, the high-dose intralesional steroid injection group achieved a one hundred percent complete response rate. In contrast, patients receiving combination treatments showed a seventy-five percent response rate, indicating variable outcomes across different modalities. Although oral steroids provided initial relief, the recurrence rate of twelve point five percent suggests a need for long-term monitoring. Moreover, surgical options like blepharoplasty or debulking proved beneficial for patients with significant hypertrophic changes. Therefore, early intervention using potent local therapies may significantly improve the clinical trajectory for affected individuals.
The condition is primarily characterized by chronic, firm, non-pitting edema and erythema affecting the eyelids and the upper face.
According to recent study data, high-dose intralesional triamcinolone injections (20 mg/mL) provide superior complete response rates compared to oral therapies.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Always seek the advice of a qualified healthcare provider regarding any medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Choi YA et al. Clinical characteristics and treatment of Morbihan disease of the eyelids: A single-center retrospective study. Indian J Ophthalmol. 2026 Mar 12. doi: 10.4103/IJO.IJO_1493_25. PMID: 41817577.
van der Linden MMD, et al. Diagnosis and Treatment of Morbihan's Disease: A Practical Approach based on Review of the Literature. J Clin Aesthet Dermatol. 2023;16(10):22-30.
Salas-Alanís JC, et al. Morbihan disease. AME Med J. 2024;9:24.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A retrospective study of 24 patients explores the clinical features and treatment outcomes of Morbihan disease, highlighting the success of intralesional st...
7 months ago

A prospective multicenter cohort study demonstrates that baseline health-related quality of life, particularly physical functioning, independently predicts all-cause maintenance hemodialysis mortality. Assessing patient-reported outcomes provides vital prognostic value beyond standard biochemical markers.
Today

Delhi is undergoing a major healthcare overhaul with enhanced Ayushman Bharat insurance up to ₹10 lakh, increased MBBS and PG medical training seats, expanded primary network mandirs, new tertiary neuro-ICUs, and public-private reproductive technology initiatives to build a resilient, preventative healthcare model.
Today

Aon forecasts India's healthcare inflation will ease to 10.1% in 2027 from 11.5% in 2026. Despite moderation, healthcare expenses continue to outpace general inflation, propelled by non-communicable diseases, advanced medical therapeutics, and expanding utilization patterns across diverse patient populations.
Today

Non-union fractures occur in 2-5% of cases, causing significant disability and cost. Conservative modalities such as LIPUS, PEMF, and focused ESWT offer non-surgical healing options for defects up to 5-10 mm when adequate mechanical stability exists without infection.
Today

Explore how novel oxygen-releasing PVA hydrogels prevent early post-transplant hypoxic damage in pancreatic beta cells, sustaining viability and insulin secretory function.
Today